ArriVent BioPharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ArriVent BioPharma, Inc.
CIK #0001868279
EDGAR Form CIK 2011 - 2025
10-K [0001868279]
10-Q [0001868279]
3 [0001868279]
4 [0001868279]
8-K [0001868279]
D [0001868279]
SC 13D [0001868279]
SC 13G [0001868279]
Form 13D/13G Filer Form 13D/13G Subject Filed
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-08-13]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-05-15]
Novo Holdings A/S Arrivent Biopharma Inc [2025-02-14]
Suvretta Capital Management LLC Arrivent Biopharma Inc [2024-12-04]
HHLR Advisors Ltd Arrivent Biopharma Inc [2024-11-14]
Sofinnova Venture Partners Xi LP Arrivent Biopharma Inc [2024-11-12]
FMR LLC Arrivent Biopharma Inc [2024-11-12]
BlackRock Inc Arrivent Biopharma Inc [2024-11-08]
BlackRock Inc Arrivent Biopharma Inc [2024-10-24]
Octagon Capital Advisors LP Arrivent Biopharma Inc [2024-10-11]
View All
Form 3/4/5 Subject 2011 - 2025
ArriVent BioPharma, Inc.
LaChapelle Robin
Parsey Merdad
Peterson Kristine
Hohneker John
Nolet Chris
Kastenmayer James Paul
Yao Zhengbin
Lutzker Stuart
Kung Winston
HHLR Advisors Ltd
Hillhouse Investment Management Ltd
Gordon Carl L
Healy James
OrbiMed Asia GP IV, L.P.
OrbiMed Advisors LLC
OrbiMed Advisors IV Ltd
OrbiMed Capital GP VIII LLC
Jallal Bahija
Terms | Privacy | Guide
tony@aum13f.com